Celldex Therapeutics CFO Sam Martin to retire by March 31, 2027; search underway

Celldex Therapeutics, Inc.

Sam Martin, SVP and CFO, notified of his retirement effective on or about March 31, 2027.
Martin joined Celldex in April 2009 and has served as CFO since July 2017.
Company has initiated a search for a new CFO; Martin will continue until successor or March 31, 2027.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Sam Martin

Senior Vice President and Chief Financial Officer

CLDX · Celldex Therapeutics, Inc.

Effective: 2027-03-31
Filed: July 15, 2026, 4:07 PM ET

On July 10, 2026, Sam Martin, Senior Vice President and Chief Financial Officer of Celldex Therapeutics, Inc. (the “Company”), notified the Company of his plans to retire effective on or about March 31, 2027.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sam Martin departed as Senior Vice President and Chief Financial Officer at Celldex Therapeutics, Inc..

Action: retire
Role: Senior Vice President and Chief Financial Officer

Exact text from the filing

On July 10, 2026, Sam Martin, Senior Vice President and Chief Financial Officer of Celldex Therapeutics, Inc. (the “Company”), notified the Company of his plans to retire effective on or about March 31, 2027.

View on SEC.gov

Celldex Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-083880

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.